Latest News about Biotechnology
Recent news which mentions Biotechnology
Gilead stock falls after disappointing lung cancer study results
January 22, 2024
From CNBC.com News
The weight loss drug market may soon get more crowded – here are the companies trying to enter the booming space
January 17, 2024
From CNBC.com News
Biotech and pharma companies are betting on a promising class of cancer drugs to drive growth
January 14, 2024
From CNBC.com News
From CNBC.com News
J&J to acquire cancer drug developer Ambrx Biopharma for $2 billion
January 08, 2024
From CNBC.com News
Moderna Covid vaccine sales plunge by two-thirds in 2023, but meet company's $6 billion forecast
January 08, 2024
From CNBC.com News
Eli Lilly's direct drug sales may not upend the industry alone – but others could follow suit
January 05, 2024
From CNBC.com News
Florida wins first FDA approval to import cheaper drugs from Canada
January 05, 2024
From CNBC.com News
From CNBC.com News
Oil prices rise more than 3% on mounting Middle East tensions, OPEC pledge to support market
January 03, 2024
Tickers
OIL
From CNBC.com News
Moderna stock pops after Oppenheimer says Covid shot maker could launch more products over next two years
January 02, 2024
From CNBC.com News
Biden administration's Medicare drug price negotiations will face major tests in 2024
December 28, 2023
From CNBC.com News
Luna's Lunar Leap: Grabs $50M Investment To Fuel Silixa Buyout & More
December 21, 2023
Tickers
LUNA
From Benzinga
Weight loss drugs, Alzheimer's treatments and gene editing: Enormous firsts defined 2023 in pharma
December 20, 2023
From CNBC.com News
Enphase Energy will lay off roughly 10% of workforce as part of restructuring plan
December 18, 2023
From CNBC.com News
The weight loss drug boom isn't over yet — here's what to expect in the year ahead
December 17, 2023
From CNBC.com News
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.